about 5 hours ago
MIT Receives License Amendment Approval; FTC Sues to Block Omnicare's Bid: Below is a look at some of the headli... http://t.co/T67IpBMr
about 15 hours ago
Ut oh! Lpath Suspends Dosing of iSONEP in Clinical Trials: Shares of Lpath, Inc. rose over 40% since we helped b... http://t.co/H6NgHIAA
about 15 hours ago
$LPTN shares drop over 30% after they suspend trials: http://t.co/7Kx9UXIR
about 15 hours ago
Idenix Pharmaceuticals ($IDIX) down after Stifel Nicolaus downgrades shares to Sell from Hold
about 16 hours ago
Amex confirms resolution of iBio's ($IBIO) listing deficiency. In Nov. Exchange said iBio was not in compliance with Section 1003(a)(iv).
about 1 day ago
Stock Market Today: Stocks Fall Amid Mixed Economic And Earnings Reports - http://t.co/QwRjtSq5
about 1 day ago
Cornerstone Announces New Analysis Shows Lower Mortality Rates; MelApp for iPhone Application Receives Record Do... http://t.co/r2dz00DO
about 1 day ago
CEL-SCI ($CVM) $5.76M Registered Direct raise - Shares fall back a nickle in heavy trading - Warrants priced at $.50 http://t.co/5riTY3QJ


Below is a look at some of the headlines for companies that made news in the healthcare sector on January 27, 2012.
Protalix BioTherapeutics, Inc. (AMEX:PLX) gave traders another forward-looking catalyst after


